The Israel Advantage for Healthtech Innovation Program offers U.S. health technology companies and startups a unique opportunity to leverage the progressive, innovative and entrepreneurial clinical and healthcare systems in Israel. This program enables health technology companies (devices, therapeutics, diagnostics, digital, regenerative) to explore opportunities for a quicker, more cost-effective pathway to market, especially beneficial for companies focused on novel therapeutic approaches.

Question Title

* 1. Contact Information

Question Title

* 2. Personal LinkedIn Page

Question Title

* 3. Company Name

Question Title

* 4. Company Website

Question Title

* 5. Company Category

Question Title

* 6. Company Establishment Year

Question Title

* 7. Where are your offices located domestically and/or internationally (City, State if applicable, Country)?

Question Title

* 8. What are your primary products in your clinical development pipeline and for what indications? What unmet needs are being addressed?

Question Title

* 9. At what stage is your company? Have you secured funding, patents, regulatory approval, etc…?

Question Title

* 10. Do you have any existing partnerships/collaborations with health systems, hospitals, or academic institutions in the U.S.?

Question Title

* 11. On a scale from 1-10, considering the novelty of your product(s), how challenging is your path to successful regulatory approval in the U.S.? For the given scale, 10 is considered highly challenging.

0 Neutral 10
Clear
i We adjusted the number you entered based on the slider’s scale.

Question Title

* 12. In this context, what are the company’s major challenges?

Question Title

* 13. Have you considered proceeding with the regulatory process in other countries as a precursor to U.S. approval? If so, which ones?

T